BackChampions Oncology Overview

Champions Oncology Other Current Liabilities

Latest other current liabilities for CSBR: $230K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$234000.00
↓ 87.79% YoYΔ $-1.68M vs prior year quarter

Peer trimmed avg / median

Loading

Champions Oncology Other Current Liabilities History

Loading

Champions Oncology vs. peers: Other Current Liabilities Comparison

Loading

Champions Oncology Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Champions Oncology (CSBR) FAQ

Champions Oncology posts a other current liabilities of $230K as of July 2026. That compares with $1.9M in the prior-year period — down 87.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Champions Oncology's other current liabilities was $1.9M. The latest reading is $230K — a 87.8% year-over-year decrease (period ending July 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Champions Oncology's financial statement story. At $230K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CSBR's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Champions Oncology's other metric pages and overview cover the third.

Judging Champions Oncology against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $230K here, then scan peer and history charts to see if the gap is persistent.